Search News
| 92.16 Delayed Data As of Aug 20 |  +0.69 / +0.75%Today’s Change | 60.65 Today|||52-Week Range 93.67 | +27.93% Year-to-Date |
| Zoetis Inc (ZTS) CEO Juan Ramon Alaix Sold $12.4 million of Shares Aug 15 / GuruFocus News - Paid Partner Content | Mario Gabelli's Top 5 New Buys of the 2nd Quarter Aug 14 / GuruFocus News - Paid Partner Content |
| Raub Brock Capital Management LP Buys Zoetis Inc, Sells Magellan Midstream Partners L... Aug 14 / GuruFocus News - Paid Partner Content |
| Previous close | 91.47 |
| Today’s open | 91.60 |
| Day’s range | 91.60 - 92.59 |
| Volume | 1,175,878 |
| Average volume (3 months) | 2,503,183 |
| Market cap | $43.8B |
| Earnings growth (last year) | +6.06% |
| Earnings growth (this year) | +28.09% |
| Earnings growth (next 5 years) | +15.15% |
| Revenue growth (last year) | +8.57% |
| P/E ratio | 40.4 |
| Price/Sales | 6.69 |
| Price/Book | 24.95 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALXNAlexion Pharmaceutic... | +0.17 | +0.15% |
| BAXBaxter International... | +0.16 | +0.22% |
| INCYIncyte Corp | +0.25 | +0.36% |
| VRTXVertex Pharmaceutica... | -0.37 | -0.21% |
| Next reporting date | November 6, 2018 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $5.3B |
| Annual profit (last year) | $864.0M |
| Net profit margin | 16.28% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
Chief Executive Officer & Director Juan Ramón Alaix |
Executive Vice President & President-US Operations Kristin C. Peck |
Corporate headquarters New Jersey, New Jersey |
